Conveners
[LH1] Navigating a Post COVID-19 World: Strengthening global resilience against unprecedented infectious diseases
- Moo-Seung Lee (Korea Research Institute of Bioscience and Biotechnology)
- Baek-Soo Han (Korea Research Institute of Bioscience and Biotechnology)
Description
The COVID-19 pandemic has highlighted the vulnerability of our global community to infectious diseases and underlined the importance of a coordinated, international response. In the vast expanse of our global health landscape, the COVID-19 pandemic has felt like an overwhelming storm, testing the resilience of our societies and our healthcare systems. As we steer our way into the aftermath, we must focus on the changing map of infectious diseases including bacterial pathogens besides viral disease, and set our compass to navigate this evolving world. In the aftermath of the COVID-19 pandemic, the global community finds itself at a crossroads. This relentless virus has laid bare our vulnerabilities, shattering notions of invincibility and setting us adrift on uncharted waters. As we look to regain our bearings, our gaze is set on the horizon, towards the unknown future of infectious diseases. Notably, after the pandemic, there has also been considerable interest in research on antibiotic-resistant bacterial infections. Our session, " Navigating a Post COVID-19 World: Strengthening global resilience against unprecedented infectious diseases," aspires to be the astrolabe for this complex journey. This session aims to foster a comprehensive understanding of the multifaceted approach needed to tackle future infectious disease outbreaks. Participants will gain insights into the adaptations necessary in healthcare systems, technological innovation, vaccine distribution, and the crucial role of global collaboration. The knowledge and strategies exchanged in this session will contribute to the global preparedness and resilience against future pandemics. Target Audience:
Public health officials, epidemiologists, policy makers, health economists, virologists, technology innovators in health, ethicists, logistic specialists, and representatives from international health organizations and NGOs. By uniting global experts in a shared dialogue, we will create a robust platform to collaboratively address the challenge of infectious diseases in our post-COVID world.
Mathematical models and cost-effectiveness analyses have been playing a major role when UK policymakers consider changes in the UK national vaccination programmes. As an example, I would like to introduce my mathematical modelling work on paediatric pertussis vaccination programmes in the UK. Pertussis, also known as whooping cough, had been a leading cause of childhood morbidity and mortality...
Escherichia coli is a major constituent of the gut microbiota of mammals. Despite this frequent symbiosis, some strains of E. coli are pathogenic. According to the World Health Organization (WHO), foodborne Shiga toxin-producing Escherichia coli (STEC) caused more than 1,000,000 illnesses, leading to more than 100 deaths and approximately 13,000 disability-adjusted life years (DALYs) in 2020....
Currently, our society faces an urgent need for early response technologies to address chemical, biological, radiological, and nuclear (CBRN) threats that may arise in various scenarios, including terrorism, disasters, and attacks. To tackle these challenges, the Next-Generation Biodefense Research Lab (NGBRL) was established in 2019 at the Korea Institute of Bioscience and Biotechnology.
The...
